- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Nath Bio-Genes reported strong Q3FY26 revenue up 79% to ₹66 Cr & profits up 67% to ₹4.5 Cr. 9MFY26 revenue rose 23% to ₹385.9 Cr, PAT up 1% to ₹39.9 Cr. Key crop growth in Maize (+142% value), Vegetables (+52%), Cotton (+25%). Uzbekistan JV is successful.